Vision & Mission

VISION

• Creation of values through innovative technology
• Realization of biomedical business value

STRATEGY

• Development of cutting-edge biomedical technology
• Structure of business competence
  

GOAL

• Commercialization & globalization of advanced topical hemostat

Well-organized Working members

• Specialized in biomaterials, and biomedical engineering
• Solid experiences in biomedical / pharmaceutical industries

Unique & Advanced Technology

• Advanced biopolymer modification / formulation technology
• Platform technology embodied in biocompatible / biodegradable polymer

Promising Profitability

• Well-established market; Topical hemostat for human and Styptic products for pet animal
• GAGR app .9% and 18% for each product segment

Long-term Sustainability

• Scalability of the technique to biomedical / pharmaceuticals
  
• Going for cutting-edge biomedical technology → Artificial organs and Tissue engineering